A system for non-invasively detecting changes in human tissues, the system comprising: an Electrical Impedance Tomography (EIT) sensor capable of acquiring readings associated with a group of human tissues of a patient; and a processing resource configured to: obtain reference state information based on a reference EIT reading obtained at a past time, the reference state information being indicative of a reference state of the group of human tissues; acquire, using the EIT sensor, a current reading; analyze the current EIT reading to determine current state information indicative of a current state of the group of human tissues; compare the reference state information with the current state information to determine a change between the reference state of the group of human tissues and the current state of the group of human tissues; and provide output indicative of the change, or lack thereof, to a user of the system.

A cable comprises a circuit, a switching element and an input connection for engaging an output connection of a sensor, the switching element configured to selectively enable the circuit of the cable assembly to process an accepted output of at least one of at least two sensors providing differing acceptable outputs and to provide a signal output corresponding to the accepted sensor output for processing by a monitor. A sensor includes an initiation element structured to cause a switching element associated with an input connection of the cable to change a mode of operation of the switching element to selectively enable the circuit to process an output of the sensor accepted by the cable and to provide a signal output corresponding to the accepted sensor output. A system comprises a monitor and the cable including the circuit and the switching element. Methods of operation are also disclosed.

The invention provides a system for monitoring a fetus in a pregnant woman, and/or the maternal health risk for pregnancies complicated by such as pre-eclampsia and hypertensive disorders. The system comprises a portable or wearable unit that can be worn by the pregnant woman, preferably so as to allow monitoring during daily life, e.g. in the form of an adhesive patch. The portable unit has a sound sensor, e.g. a microphone or accelerometer, to be positioned on the skin of the abdominal area of the pregnant woman so as to detect a vascular sound from umbilical arteries of the fetus or from the uterine arteries of the pregnant woman. The sound sensor is functionally connected to a processing unit which executes a processing algorithm on the captured vascular sound and extracts a signal parameter accordingly, e.g. the Pulsatility Index. The processing unit then communicates the signal parameter, e.g. using an audio signal, a visual display or by means of a wired or a wireless data signal. Some embodiments include one or more additional sensors, such as a sensor for detecting fetal electrocardiographic signals, and/or a sensor for detecting uterus electromyographic activity. Especially, the sound sensor and such additional sensor(s) may be arranged within one adhesive patch or several adhesive patches.

The disclosed apparatus, systems and methods relate to tracking abdominal orientation and activity for purposes of preventing or treating conditions of pregnancy or other types of medical conditions. In certain specific embodiments, the system, device, or method relates to identifying abdominal orientation risk values, calculating and updating a cumulative risk value, comparing the cumulative risk value to a threshold, and outputting a warning when the cumulative risk value crosses the threshold.

The present disclosure relates generally to the field of pregnancy devices. More specifically, the present disclosure relates to a wearable apparatus that alerts an expecting mother of unsafe lying or sleeping positions. An exemplary wearable apparatus consistent with the present disclosure comprises an adjustable belt member having an elongated axis of sufficient length to cover the girth of an expecting mother during the entire term of her pregnancy. Further, an attachment coupled to the wearable apparatus is present to secure the alarm belt to the expecting mother. In addition, sensors coupled to the wearable apparatus detect when the expecting mother is lying or sleeping in a supine position in which the sensors send signals to an external alarm. Furthermore, a power source may be coupled to the sensors to provide power thereto.

A method for assessment and/or monitoring a person's cardiovascular state comprises: using a sound and vibration transducer to acquire a vascular sound signal in order to detect a vascular sound from a cervical, thoracic, abdominal, pelvic, or lower limb region of the person; filtering the vascular sound signal to isolate the vascular sound, said filtering using a filter which attenuates frequencies below a lower cut-off frequency in a range of 100-300 Hz; and analyzing the filtered sound signal in order to determine whether an indication of a dicrotic notch in the vascular sound exceeds a set threshold.

A multi-use testing device is disclosed that is able to test a user fluid or dissolved tissue samples for a medical condition comprising, e.g.: blood related, heart (FABS enzymes); liver and kidney function; gene mutations; COVID-19; and pregnancy status. The testing device is positioned in a bio-fluid chamber configured to store at least one electrolyte or charging fluid to create a conductive path for electrons emitted by an anode electrode and a cathode electrode to generate electricity to recharge the micro battery. The generated electricity is transferred to power the testing device. The reusable testing device further comprises a computing device configured to control the communication between a user electronic computing device and the testing device. The reusable testing device is dipped into a sample in a container and outputs the encrypted test result for wireless transmission to electronic computing devices.

Methods and a system are provided for assessing postpartum hemorrhage risk and postpartum hemorrhage stages in a clinical setting. Generally, a clinician may indicate that the mass of several bloody items, indicated in type and quantity, is to be measured using a scale. The mass of bloody items is compared to the known unused dry mass of such items in order to accurately determine the quantitative blood loss (QBL) of a patient at the bedside. The cumulative QBL can be updated by weighing additional items. Based on the cumulative QBL, the patient's vital signs, and other factors, a corresponding hemorrhage stage is identified and communicated to the clinician. Recommendations specific to the hemorrhage stage are provided to a clinician. Some recommendations are selectable actions that trigger automatic placement of medical orders and notifications to relevant medical services, such as a blood bank or anesthesia.

A vaginal dilation device is provided that may include any of a number of features. One feature of the vaginal dilation device is that it is configured to dilate vaginal tissue during labor to prevent tissue damage. Another feature of the vaginal dilation device is that it can be manually controlled to dilate vaginal tissue, or can be automatically controlled to dilate vaginal tissue. In some embodiments, the vaginal dilation device is configured to measure a force applied by the device to tissue. In other embodiments, the vaginal dilation device is configured to apply a constant force to tissue. In other embodiments, the vaginal dilation device is configured to expand at a constant rate. Methods associated with use of the vaginal dilation device are also provided.

Technology is disclosed for a cat litter that can be used to diagnose feline medical conditions. A cat litter contains an additive, e.g., a chemical agent, such as a natural and/or synthetic agent, that changes in color when it comes in contact with cat urine or feces. Based on the color it can be determined whether the cat has a medical condition, such as particular illness. For example, if the litter turns yellow when it comes in contact with the urine, it can indicate that the cat is healthy. If the litter turns to a color other than yellow, e.g., green, it can indicate that the cat has some illness. The cat then be taken to a veterinary doctor for further diagnosis. The chemical agent aids in detection and diagnosis through interaction of materials that change colors to indicate reactions with specific chemicals, cells, molecules, DNA and/or materials. The technology can be implemented for medical diagnosis and detection—for humans and/or animals.